- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 245/00 - Composés hétérocycliques contenant des cycles de plus de sept chaînons comportant deux atomes d'azote comme uniques hétéro-atomes du cycle
Détention brevets de la classe C07D 245/00
Brevets de cette classe: 25
Historique des publications depuis 10 ans
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3715 |
3 |
| Bristol-myers Squibb Company | 4812 |
1 |
| International Business Machines Corporation | 62220 |
1 |
| Bridgestone Corporation | 7234 |
1 |
| The United States of America as represented by the Secretary of the Navy | 2837 |
1 |
| The Regents of the University of Michigan | 4903 |
1 |
| The General Hospital Corporation | 4809 |
1 |
| AllAccem, Inc. | 25 |
1 |
| AnaSpec Incorporated | 15 |
1 |
| Baruch S. Blumberg Institute | 36 |
1 |
| Board of Trustees of the University of Arkansas | 824 |
1 |
| The Broad Institute, Inc. | 1927 |
1 |
| Carnegie Mellon University | 1606 |
1 |
| Drexel University | 1015 |
1 |
| ISP Investments Inc. | 450 |
1 |
| MSD Italia S.r.l. | 51 |
1 |
| Novaled AG | 98 |
1 |
| OPTI Medical Systems | 8 |
1 |
| Phenomix Corporation | 17 |
1 |
| SETA BioMedicals, LLC | 9 |
1 |
| Autres propriétaires | 3 |